Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Carol PenaRonald M Bukowski

Abstract

Plasma proteins [vascular endothelial growth factor (VEGF), soluble VEGF receptor 2 (sVEGFR-2), carbonic anhydrase IX (CAIX), tissue inhibitor of metalloproteinase 1 (TIMP-1), and Ras p21] and one tumor gene (VHL) were analyzed to identify prognostic biomarkers or indicators of response to sorafenib in a subset of patients enrolled in the Treatment Approaches in Renal Cancer Global Evaluation Trial. Nine hundred three patients with advanced renal cell carcinoma (RCC) were randomized to 400 mg sorafenib twice a day or placebo. Samples collected at baseline and after 3 and 12 weeks were subjected to enzyme-linked immunosorbent assays. VHL exons were sequenced from tumor biopsies. Baseline biomarker data were available for VEGF (n = 712), sVEGFR-2 (n = 713), CAIX (n = 128), TIMP-1 (n = 123), Ras p21 (n = 125), and VHL mutational status (n = 134). Higher Eastern Cooperative Oncology Group performance status (ECOG PS) score correlated with elevated baseline VEGF (P < 0.0001) and a higher incidence of VHL mutations (P = 0.008), whereas higher Memorial Sloan-Kettering Cancer Center (MSKCC) score correlated with elevated VEGF (P < 0.0001), CAIX (P = 0.027), and TIMP-1 (P = 0.0001). Univariable analyses of baseline levels in the placebo...Continue Reading

References

Oct 21, 1998·Oncogene·S L CampbellC J Der
Aug 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L ManentiR Giavazzi
Jan 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerMadhu Mazumdar
Nov 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I Rini, Eric J Small
Apr 22, 2005·Biological Chemistry·Klaudia Giehl
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Muralidhar BeeramEric K Rowinsky
Mar 2, 2006·Journal of the National Cancer Institute·Francesca CarlomagnoMassimo Santoro
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Robert J MotzerM Dror Michaelson
Oct 4, 2006·Nature Reviews. Drug Discovery·Scott WilhelmSusan Kelley
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William G Kaelin
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anat Norden-ZfoniJohn V Heymach
Jul 28, 2007·Pharmacotherapy·Cheryl A Grandinetti, Barry R Goldspiel
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·John M L EbosRobert S Kerbel
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley C LeibovichEugene D Kwon
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinKathy D Miller
Apr 24, 2008·BJU International·Silvia PastorekovaJaromir Pastorek
May 29, 2008·International Journal of Cancer. Journal International Du Cancer·Paula KuvajaTaina Turpeenniemi-Hujanen
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I RiniDaniel J George
Mar 10, 2009·Lancet·Brian I RiniBernard Escudier
Apr 25, 2009·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Takaki YoshikawaOsamu Kobayashi
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Aug 13, 2009·Current Pharmaceutical Design·Volker H Haase

❮ Previous
Next ❯

Citations

Aug 11, 2012·Cancer Chemotherapy and Pharmacology·Hiroshi NokiharaTomohide Tamura
Mar 22, 2012·Current Oncology Reports·Maria Hernandez-YanezAmado J Zurita
Sep 25, 2012·Nature Reviews. Cancer·Barbara Sennino, Donald M McDonald
Apr 6, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A J ZuritaJ V Heymach
Oct 21, 2011·Journal of Gastroenterology and Hepatology·Koji MiyaharaKazuhide Yamamoto
Nov 17, 2010·Molecular Cancer Therapeutics·Sumanta Kumar PalRobert A Figlin
May 29, 2012·Molecular Cancer Research : MCR·Eric JonaschW Kimryn Rathmell
Jan 16, 2014·Cancer Cell International·Saadia A AzizHarriet M Kluger
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Holger MochPuay Hoon Tan
Jun 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Garcia-DonasC Rodríguez-Antona
Feb 4, 2016·Expert Review of Molecular Diagnostics·Meta H M DiekstraHenk-Jan Guchelaar
Mar 20, 2014·Expert Review of Anticancer Therapy·Yann-Alexandre VanoStephane Oudard
Nov 22, 2011·Expert Opinion on Pharmacotherapy·Shilpa Gupta, Mayer Fishman
Apr 4, 2015·Expert Review of Molecular Diagnostics·Jason Yongsheng ChanMin-Han Tan
Dec 13, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Grace K DyAlex A Adjei
Jan 13, 2016·Cancer Immunology, Immunotherapy : CII·Anastasia DielmannAntonia Busse
Oct 4, 2014·Journal of Hematology & Oncology·Alan D SmithTimothy A Yap
Jul 15, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·N Romero-LaordenJ Garcia-Donas
Jun 19, 2012·Seminars in Cancer Biology·Rosalie FisherJames Larkin
Nov 8, 2011·European Urology·Guru SonpavdeChristian G Stief
Jul 19, 2011·Hematology/oncology Clinics of North America·Patricia A TangDaniel Y C Heng
Jul 19, 2011·Hematology/oncology Clinics of North America·Lianjie Li, William G Kaelin
Oct 9, 2013·Tuberculosis and Respiratory Diseases·Seon-Sook HanMyeong Ju Cheon
Nov 29, 2015·The Urologic Clinics of North America·Andrew G WinerA Ari Hakimi
Apr 13, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Hai-Liang ZhangDing-Wei Ye
Mar 24, 2016·Urologic Oncology·Francesca MalentacchiPamela Pinzani
Oct 24, 2014·Journal of Internal Medicine·C Rodríguez-Antona, M Taron
Feb 28, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Takashi KarashimaTaro Shuin
Jul 7, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Nobuo Shinohara, Takashige Abe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.